United States: Post-Trial Updates On Regeneron V. Mylan (Aflibercept) BPCIA Litigation - Goodwin Procter LLP

Mondaq

11 Mar 2024 0 shares 1 views

Mondaq

Published 11 Mar 2024

Appeals from and redacted memorandum and opinion in support of judgment in Regeneron v. Mylan (aflibercept) BPCIA case filed

United States: Updates On Aflibercept BPCIA Litigation - Goodwin Procter LLP

As we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") filed a motion seeking to establish a..

Mondaq 26 Mar 2024

On March 4, Biocon Biologics Ltd. announced it has signed a settlement agreement with Bayer Inc. and Regeneron Pharmaceuticals,..

Mondaq 15 Mar 2024